Descubra el nuevo Chem-Impex: donde la innovación comienza con un vínculo.

Catalog Number:
37768
CAS Number:
163042-96-4
Cloro-IB-MECA
Purity:
≥ 98 % (HPLC)
Synonym(s):
Cl-IB-MECA, 2-Cloro- N 6-(3-yodobencil)adenosina-5'- N -metiluronamida
Documents
$222.93 /10 mg
Tamaño
Request Bulk Quote
Información del producto

Chloro-IB-MECA is a potent and selective agonist of the adenosine A3 receptor, making it a valuable compound in pharmacological research and drug development. This compound is recognized for its potential therapeutic applications, particularly in the treatment of various inflammatory and autoimmune diseases. Its unique structure, featuring a chloro substituent and a purine base, enhances its binding affinity and selectivity, which is crucial for researchers looking to explore adenosine receptor pathways.

In laboratory settings, Chloro-IB-MECA has been utilized to investigate the role of adenosine A3 receptors in cellular signaling and their implications in cancer biology. Its ability to modulate immune responses positions it as a candidate for developing novel anti-inflammatory agents. Researchers appreciate its favorable pharmacokinetic properties, which facilitate in vivo studies. Overall, Chloro-IB-MECA stands out as a significant tool for advancing our understanding of adenosine receptor functions and developing targeted therapies.

Número CAS
163042-96-4
Fórmula molecular
C18H18ClIN6O4
Peso molecular
544.73
Número MDL
MFCD01861178
Punto de fusión
207 - 211 °C
Condiciones
Conservar entre 2 y 8 °C.
Información general
Número CAS
163042-96-4
Fórmula molecular
C18H18ClIN6O4
Peso molecular
544.73
Número MDL
MFCD01861178
Punto de fusión
207 - 211 °C
Condiciones
Conservar entre 2 y 8 °C.
Propiedades
¡Pronto habrá más información sobre la propiedad!
-
Seguridad y normativas
Materiales peligrosos
-
Antibiótico
-
Regulado por la DEA
No
Advertencias
-
Aplicaciones

Chloro-IB-MECA is widely utilized in research focused on:

  • Pharmaceutical Development: This compound is significant in the development of drugs targeting the adenosine receptor system, which plays a crucial role in various physiological processes. Its unique structure allows for enhanced binding affinity, making it a valuable candidate for new therapeutic agents.
  • Cancer Research: Researchers are exploring its potential in oncology, particularly in modulating tumor microenvironments. Chloro-IB-MECA may help in developing treatments that improve the efficacy of existing cancer therapies.
  • Neurological Studies: Its application in neuropharmacology is promising, especially in studying neurodegenerative diseases. The compound's ability to influence adenosine pathways could lead to breakthroughs in managing conditions like Alzheimer's and Parkinson's disease.
  • Cardiovascular Research: Chloro-IB-MECA is being investigated for its effects on heart health, particularly in understanding how it can help regulate blood flow and reduce ischemic damage during heart attacks.
  • Immunology: The compound shows potential in modulating immune responses, making it a candidate for research into autoimmune diseases and inflammatory conditions, where controlling the immune system is crucial.

Citas